Current:Home > StocksCVS pulls certain cold medicines from shelves. Here's why -WealthDrive Solutions
CVS pulls certain cold medicines from shelves. Here's why
Rekubit Exchange View
Date:2025-04-08 03:59:46
CVS is pulling over-the-counter allergy and cold medicines that contain the most popular decongestant ingredient from its shelves. The ingredient, phenylephrine, was found to be no more effective than a placebo when taken orally by the U.S. Food and Drug Administration last month.
"We are removing a small number of oral decongestant products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores but will continue offering many other oral cough and cold products to meet consumer needs," a spokesperson for CVS Health told USA TODAY in a statement.
Phenylephrine can be found in name brand decongestants such as Sudafed and Dayquil, and became the primary ingredient in most of these medications after a 2006 law limited access to pseudoephedrine, which can be used to make methamphetamine.
Products like Dayquil will remain on CVS shelves since they have a combination of active ingredients.
More:FDA panel declares decongestant phenylephrine ineffective. What it is and what products contain it
Since 2007, the efficacy of phenylephrine to provide nasal congestion relief has been challenged.
In September, the group of FDA-assembled advisors unanimously voted oral phenylephrine ineffective "a thorough review of" data going back to 1994, and that the drug metabolizes in the body before it reaches the nasal passages. The panel vote is not a medical determination.
There were no safety issues found with taking oral phenylephrine.
The experts said some potential benefits of removing the ingredient include "lowering of overall healthcare costs, and avoiding missed opportunities for use of more effective treatments" like going to the doctor.
Medications with phenylephrine generated $1.8 billion in sales last year, according to the FDA report.
Not all pharmacy chains will remove products. In a statement to USA TODAY, a Rite Aid spokesperson said the company will keep those over-the-counter medications on its shelves:
"Our pharmacists are available to provide guidance to customers on over-the-counter solutions for alleviating symptoms associated with colds and other illnesses."
Kathleen Wong is a travel reporter for USA TODAY based in Hawaii. You can reach her at [email protected].
veryGood! (26)
Related
- Federal Spending Freeze Could Have Widespread Impact on Environment, Emergency Management
- See Khloe Kardashian’s Delicious Chocolate Hair Transformation
- The head of Boeing’s defense and space business is out as company tries to fix troubled contracts
- The head of Boeing’s defense and space business is out as company tries to fix troubled contracts
- Google unveils a quantum chip. Could it help unlock the universe's deepest secrets?
- Estranged husband arrested in death of his wife 31 years ago in Vermont
- Caitlin Clark rewrites WNBA record book: Inside look at rookie's amazing season
- California governor to sign a law to protect children from social media addiction
- North Carolina justices rule for restaurants in COVID
- Poll shows young men in the US are more at risk for gambling addiction than the general population
Ranking
- 'No Good Deed': Who's the killer in the Netflix comedy? And will there be a Season 2?
- Bear injures hiker in Montana's Glacier National Park; section of trail closed
- The Fate of Pretty Little Liars Reboot Revealed After 2 Seasons
- The legacy of 'Lost': How the show changed the way we watch TV
- Civic engagement nonprofits say democracy needs support in between big elections. Do funders agree?
- 'Golden Bachelorette': Gil Ramirez's temporary restraining order revelation prompts show removal
- The latest: Kentucky sheriff faces murder charge over courthouse killing of judge
- ATTN: Target’s New Pet Collab Has Matching Stanley Cups and Accessories for You and Your Furry Friend
Recommendation
Are Instagram, Facebook and WhatsApp down? Meta says most issues resolved after outages
Google begins its defense in antitrust case alleging monopoly over advertising technology
Secret Service’s next challenge: Keeping scores of world leaders safe at the UN General Assembly
8 California firefighters injured in freeway rollover after battling Airport Fire
Can Bill Belichick turn North Carolina into a winner? At 72, he's chasing one last high
Shohei Ohtani makes history with MLB's first 50-homer, 50-steal season
Cards Against Humanity sues Elon Musk's SpaceX over land bought to curb Trump border wall
Over 137,000 Lucid beds sold on Amazon, Walmart recalled after injury risks